DADC
PJP icon

D.A. Davidson & Co’s Invesco Pharmaceuticals ETF PJP Stock Holding History

D.A. Davidson & Co’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-99
Closed -$6K – 1751
2017
Q2 		$6K Hold
99
– – ﹤0.01% 2171
2017
Q1 		$5K Buy
+99
New +$5.79K ﹤0.01% 2176

Other funds holding PJP

TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

D.A. Davidson & Co's PJP Position: Q3 2017 in Review

D.A. Davidson & Co sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2017, closing a stake of 99 shares — an estimated $6K sold.

D.A. Davidson & Co first reported a position in PJP in Q1 2017 and held it in 2 quarters. The position peaked at $6K in Q2 2017. 90 funds tracked by Wall St. Rank hold PJP as of Q3 2017.

  • D.A. Davidson & Co reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 99 Invesco Pharmaceuticals ETF shares in Q3 2017, an estimated $6K.
  • D.A. Davidson & Co first reported a position in Invesco Pharmaceuticals ETF in Q1 2017 and held it in 2 quarters.
  • D.A. Davidson & Co's Invesco Pharmaceuticals ETF position peaked at $6K in Q2 2017.
  • 90 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.